Dr. Devi Sampat, MD
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Alabama School of Medicine (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 552
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: University of Alabama School of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
GA license 89007 -
Hematology (Internal Medicine) Physician
GA license 89007 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northeast Georgia Medical Center, Inc Gainesville, GA
- Northeast Georgia Medical Center Habersham Demorest, GA
Medical groups
- The Longstreet Clinic, PC (140 clinicians)
- Northeast Georgia Community Physicians LLC (131 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 552
- Services billed
- 132,706
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, dexamethasone sodium phosphate, 1 mg | 1,432 | 15 |
| Insertion of needle into vein for collection of blood sample | 364 | 115 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 339 | 102 |
| Established patient office or other outpatient visit, 30-39 minutes | 322 | 142 |
| Blood test, comprehensive group of blood chemicals | 255 | 80 |
| Administration of chemotherapy into vein, 1 hour or less | 135 | 20 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 124 | 18 |
| Established patient office or other outpatient visit, 20-29 minutes | 97 | 74 |
| Injection, diphenhydramine hcl, up to 50 mg | 88 | 14 |
| Administration of additional new drug or substance into vein, 1 hour or less | 81 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Gainesville, GA | 217 |
| Eliquis (apixaban) Other prescribers in Gainesville, GA | 123 |
| Letrozole Other prescribers in Gainesville, GA | 93 |
| Lenalidomide | 63 |
| Alendronate Sodium Other prescribers in Gainesville, GA | 60 |
| Prednisone Other prescribers in Gainesville, GA | 59 |
| Acyclovir Other prescribers in Gainesville, GA | 53 |
| Ondansetron Odt (ondansetron) Other prescribers in Gainesville, GA | 51 |
| Ondansetron Hcl Other prescribers in Gainesville, GA | 44 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Gainesville, GA | 40 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 41 companies reported 137 payments worth $3,089 in total to this clinician.
| Pfizer Inc. | $276 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $241 |
| Janssen Biotech, Inc. | $217 |
| Daiichi Sankyo Inc. | $201 |
| AbbVie Inc. | $193 |
| GlaxoSmithKline, LLC. | $155 |
| Merck Sharp & Dohme LLC | $145 |
| Incyte Corporation | $126 |
| Food and Beverage | $3,041 |
|---|---|
| Education | $48.03 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Oct 31, 2025 | Education TUKYSA · ONCOLOGY · in-kind | $16.01 |
| Pfizer Inc. Aug 22, 2025 | Education TUKYSA · ONCOLOGY · in-kind | $16.01 |
| Pfizer Inc. Oct 15, 2025 | Education TUKYSA · ONCOLOGY · in-kind | $16.01 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.